Plain-English translation of NCT06377761 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a traditional Chinese medicine called to see if it can help people with a type of heart failure called HFpEF (heart failure with preserved ejection fraction). You would take the medication twice a day for 3 months while continuing your regular heart medications. Researchers will measure how much oxygen your body can use during exercise and how your quality of life improves.
Heart failure with preserved ejection fraction is common and affects many people in China, but current treatments have limits. Earlier studies suggest that combining traditional Chinese medicine with standard heart medications may help people exercise better and enjoy life more, so researchers want to carefully test whether this treatment really works.
You likely qualify if…
You likely don't qualify if…
You would take the medication (or placebo) twice a day for 90 days on top of your regular heart medications. The study team will test your heart's ability to use oxygen during exercise, take ultrasound images of your heart, check blood markers, and ask you questions about how you are feeling and your quality of life. You will be randomly assigned to receive either the actual medication or a placebo that looks and tastes the same, so neither you nor the researchers will know which one you are taking.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China